Abemaciclib is a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). Structurally, it is a pyrimidine-based compound. Chemically, abemaciclib is (R)-N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(7-fluoro-2-methylimidazo[1,2-a]pyridin-3-yl)pyrimidin-2-amine. This unique chemical structure allows abemaciclib to selectively inhibit the activity of CDK4/6, key enzymes involved in regulating the cell cycle.Abemaciclib is indicated for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. It is typically used in combination with hormonal therapy or other targeted therapies, such as aromatase inhibitors or fulvestrant, for the treatment of postmenopausal women with HR+, HER2- advanced breast cancer who have progressed on endocrine therapy. Abemaciclib works by inhibiting CDK4/6-mediated phosphorylation of retinoblastoma protein (Rb), leading to cell cycle arrest and inhibition of tumor cell proliferation. Clinical trials have demonstrated the efficacy of abemaciclib in improving progression-free survival and overall survival in patients with advanced breast cancer.
Buy high quality Abemaciclib from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Abemaciclib.